BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6461194)

  • 1. [Effects of antiarrhythmic drug changrolin on myocardial contractility in anesthetized dogs (author's transl)].
    Shen YT; Wu PM; Wan FT; Chen WZ; Dong YL
    Zhongguo Yao Li Xue Bao; 1981 Mar; 2(1):23-6. PubMed ID: 6461194
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cardiovascular effect of a new antiarrhythmic drug--changrolin (author's transl)].
    Chen WZ; Dong YL; Ding GS
    Yao Xue Xue Bao; 1979 Dec; 14(12):710-4. PubMed ID: 554432
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of changrolin on contractility and excitability of isolated cat papillary muscle].
    Li RS; Chen WZ; Zhang YF; Ding GS
    Zhongguo Yao Li Xue Bao; 1984 Mar; 5(1):26-9. PubMed ID: 6232815
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on drugs for coronary diseases. II. Synthesis of compounds related to changrolin as potential antiarrhythmic drugs (author's transl)].
    Sun CJ; Zhang XY; Yang XZ; Wang PP; Shen J; Shu Y; Ji RY
    Yao Xue Xue Bao; 1981 Aug; 16(8):564-70. PubMed ID: 7324955
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effects of infusion rate of Changrolin on drug concentration in blood and ECG (author's transl)].
    Qu ZX; Cao CY; Zhuang YH
    Yao Xue Xue Bao; 1980 Aug; 15(8):449-55. PubMed ID: 7211388
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of antiarrhythmic effects of intravenous injections of changrolin and BL-4712A(author's transl)].
    Wang CG; Wang ZM; Zhang YF; Ding GS
    Zhongguo Yao Li Xue Bao; 1982 Mar; 3(1):29-31. PubMed ID: 6211899
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetic-pharmacodynamic analysis of changrolin in dogs with arrhythmia.
    Liu CX; Gu YB; Feng JL; Wei GL; Xiao SH; Sun JL
    Yao Xue Xue Bao; 1996; 31(9):666-70. PubMed ID: 9863232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nor-tropan hydantoins n-substituted: action on smooth muscle, and its antiarrhythmic and anticonvulsant effects (author's transl)].
    García Sacristán A; Illera Martín M; Sanz Sánchez F
    Arch Farmacol Toxicol; 1977 Apr; 3(1):57-66. PubMed ID: 901017
    [No Abstract]   [Full Text] [Related]  

  • 9. [Electrophysiologic effects of changrolin on the cardiac conduction system in anesthetized rabbits].
    Yu Y; Yu FS; Gu PK; Jin ZJ
    Zhongguo Yao Li Xue Bao; 1987 Sep; 8(5):421-5. PubMed ID: 3450179
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of anti-arrhythmic drug changrolin on fast and slow response potentials of myocardial cell of rats].
    Li ZY
    Zhongguo Yao Li Xue Bao; 1982 Sep; 3(3):172-5. PubMed ID: 6216725
    [No Abstract]   [Full Text] [Related]  

  • 11. [Physiological disposition of changrolin (author's transl)].
    Zeng YL; Yi QC; Gu HM; Qu ZX; Xu GY
    Zhongguo Yao Li Xue Bao; 1981 Sep; 2(3):177-81. PubMed ID: 6462008
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
    Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antiarrhythmic and parasympatholytic properties of substituted phenols. 1. Heteroarylamine derivatives.
    Stout DM; Matier WL; Barcelon-Yang C; Reynolds RD; Brown BS
    J Med Chem; 1983 Jun; 26(6):808-13. PubMed ID: 6854583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proceedings: Relation of antiarrhythmic to inotropic activity of ajmaline and its therapeutically used derivatives N-propylajmaline and di-monochloracetylajmaline.
    Raschak M
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R32. PubMed ID: 1143422
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of intravenous infusion of changrolin on cardiac function of patients with arrhythmia].
    Shen YT; Xu NS; Gu SL; Wu PM
    Zhongguo Yao Li Xue Bao; 1983 Dec; 4(4):251-3. PubMed ID: 6230869
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of changrolin and pyracrine phosphate on ATPase of rabbit heart sarcolemma].
    Chen EH; Tu ZH; Yang HH; Wu WW
    Zhongguo Yao Li Xue Bao; 1982 Sep; 3(3):183-5. PubMed ID: 6293248
    [No Abstract]   [Full Text] [Related]  

  • 17. [A study of cardiovascular and antiarrhythmic effects of alizapride (author's transl)].
    Cheymol G; Mouillé P
    Sem Hop; 1982 Feb; 58(6):333-8. PubMed ID: 6280298
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intracellular distribution of changrolin (author's transl)].
    Tu ZH; Chen EH; Wu WW; Yang HH
    Yao Xue Xue Bao; 1979; 14(10):594-7. PubMed ID: 539425
    [No Abstract]   [Full Text] [Related]  

  • 19. [Some advances in cardiovascular pharmacology (author's transl)].
    Ding GS
    Sheng Li Ke Xue Jin Zhan; 1981 Feb; 12(2):97-103. PubMed ID: 6118953
    [No Abstract]   [Full Text] [Related]  

  • 20. Inotropic and electrophysiological effects of AB--2, a new antiarrhythmic agent, on isolated cardiac preparations.
    Beresewicz A; Pytkowski B; Sedek G; Zdanowski K
    Pol J Pharmacol Pharm; 1983; 35(3):223-32. PubMed ID: 6651921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.